Nayak Sanjay 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 13, 2025
Insider Transaction Report
Form 4
Nayak Sanjay
Chief Strategy Officer
Transactions
- Award
Common Stock
2025-02-11+111,000→ 285,380 total - Award
Stock Option (Right to Buy)
2025-02-11+334,000→ 334,000 totalExercise: $7.44Exp: 2035-02-10→ Common Stock (334,000 underlying)
Footnotes (2)
- [F1]On February 11, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.